Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| 1 |
Netflix
NFLX
|
+$1.23B |
| 2 |
CVS Health
CVS
|
+$818M |
| 3 |
Microsoft
MSFT
|
+$723M |
| 4 |
Amazon
AMZN
|
+$682M |
| 5 |
Strategy Inc Common Stock Class A
MSTR
|
+$633M |
Top Sells
| 1 |
Corpay
CPAY
|
+$1.08B |
| 2 |
Booking.com
BKNG
|
+$827M |
| 3 |
ConocoPhillips
COP
|
+$544M |
| 4 |
Truist Financial
TFC
|
+$489M |
| 5 |
Merck
MRK
|
+$455M |
Sector Composition
| 1 | Technology | 22.2% |
| 2 | Communication Services | 15.23% |
| 3 | Financials | 14.97% |
| 4 | Healthcare | 13.69% |
| 5 | Industrials | 8.47% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
351
XPeng
XPEV
$20.3B
| $52.8M | 0.01% |
1,189,621
-1,676,712
| -58% | -$74.5M |
|
352
ESCO Technologies
ESE
$5.37B
| $52.4M | 0.01% |
558,209
+199,065
| +55% | +$18.7M |
|
353
Leslie's
LESL
$60.6M
| $52.3M | 0.01% |
1,900,706
+192,827
| +11% | +$5.3M |
|
|
CTLT
354
DELISTED
CATALENT, INC.
CTLT
| $50.9M | 0.01% |
471,016
| – | – |
|
355
FIGS
FIGS
$1.2B
| $50.1M | 0.01% |
+1,000,000
| New | +$50.1M |
|
356
Novavax
NVAX
$1.31B
| $49.9M | 0.01% |
235,000
| – | – |
|
357
Citigroup
C
$184B
| $49.8M | 0.01% |
703,374
-1,176,344
| -63% | -$83.2M |
|
|
CSW
358
CSW Industrials, Inc.
CSW
$4.19B
| $49.2M | 0.01% |
415,719
+175,112
| +73% | +$20.7M |
|
359
Phreesia
PHR
$1.4B
| $48.8M | 0.01% |
795,384
| – | – |
|
360
Trupanion
TRUP
$1.92B
| $48.6M | 0.01% |
422,174
+300,874
| +248% | +$34.6M |
|
361
Nexa Resources
NEXA
$670M
| $48.5M | 0.01% |
5,528,826
-169,156
| -3% | -$1.48M |
|
362
Cactus
WHD
$2.73B
| $47.8M | 0.01% |
1,300,791
| – | – |
|
|
NARI
363
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $47.8M | 0.01% |
512,050
+62,050
| +14% | +$5.79M |
|
364
Pfizer
PFE
$136B
| $47.8M | 0.01% |
1,219,493
| – | – |
|
|
RVNC
365
DELISTED
Revance Therapeutics, Inc.
RVNC
| $45.8M | 0.01% |
1,545,630
| – | – |
|
366
BioMarin Pharmaceuticals
BMRN
$10.2B
| $45.7M | 0.01% |
548,043
+1,102
| +0.2% | +$92K |
|
367
Upwork
UPWK
$2.23B
| $45.3M | 0.01% |
777,246
-300,000
| -28% | -$17.5M |
|
368
Cognex
CGNX
$7.41B
| $44.5M | 0.01% |
530,000
| – | – |
|
369
Essent Group
ESNT
$6.24B
| $44.1M | 0.01% |
980,365
+132,356
| +16% | +$5.95M |
|
370
Upstart Holdings
UPST
$6.44B
| $44M | 0.01% |
352,465
| – | – |
|
371
STAAR Surgical
STAA
$1.37B
| $43.8M | 0.01% |
287,104
-309,920
| -52% | -$47.3M |
|
372
Axalta
AXTA
$6.69B
| $42.7M | 0.01% |
1,399,600
| – | – |
|
373
Genpact
G
$7.34B
| $42.4M | 0.01% |
933,000
| – | – |
|
374
MGIC Investment
MTG
$6.45B
| $42.2M | 0.01% |
3,101,550
| – | – |
|
|
CELL
375
DELISTED
PhenomeX Inc. Common Stock
CELL
| $41.4M | 0.01% |
923,095
+262,847
| +40% | +$11.8M |
|